Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis

Introduction: The effects of sodium-glucose cotransporter 2 inhibitors (SGLT2I) and dipeptidyl peptidase-4 inhibitors (DPP4I) on new-onset cognitive dysfunction in type 2 diabetes mellitus remain unknown. This study aimed to evaluate the effects of the two novel antidiabetic agents on cognitive dysf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mui, Jonathan V., Zhou, Jiandong, Lee, Sharen, Leung, Keith Sai Kit, Lee, Teddy Tai Loy, Chou, Oscar Hou In, Tsang, Shek Long, Wai, Abraham Ka Chung, Liu, Tong, Wong, Wing Tak, Chang, Carlin, Tse, Gary, Zhang, Qingpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566991/
https://www.ncbi.nlm.nih.gov/pubmed/34746262
http://dx.doi.org/10.3389/fcvm.2021.747620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566991/
https://www.ncbi.nlm.nih.gov/pubmed/34746262
http://dx.doi.org/10.3389/fcvm.2021.747620

Ejemplares similares